Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Acyclovir 800 mg vs Zovirax in Healthy Thai Volunteers (Fasting)
TCTR20210319005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aciclovir in herpes simplex (HSV) and Varicella zoster infection (2 arms), sponsored by International Bio Service. Planned start May 2021; status: not yet recruiting.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)Varicella zoster infection
Beyond the preview
Go deeper on TCTR20210319005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210319005.